Breakthrough research at the Usona Institute revealed the true crystal forms of pharmaceutical psilocybin. It’s a new discovery of characteristics of the polymorphs of the plant that have always existed but were not detected until now.
Read Green Market Report Article
Shrooms could soon be legal in more places, and billions of dollars are in play. VICE News reports on whether psilocybin is doomed to become a therapy by and for the elite.
View Vice News Tonight / S6 EP1
A library of psychedelic knowledge, from clinical studies to turn of the century catalogs, may make psychedelic patents more fair.
Read Freethink* Article
The non-profit Freedom to Operate used research from chemists and crystallographers to argue in a legal filing that Compass’ form of synthetic psilocybin is not a new invention.
Read Tech By VICE Article
There has been a surge in patents of psychedelic therapies. Some recent headlines have suggested that patent claims on psychedelics represent a sign that “capitalism has gone rogue.” Others suggest that investors are debating ownership of a psychedelic future.
Read Psychology Today Article
By leveraging historical expertise about psychedelics, our network will help curate and increase access to disparate knowledge of psychedelic science, practice, and tradition. Ideal participants in the network will have experience with historical research on psychedelics; expertise with archival research is especially welcome.
Learn About Our Archival Researcher Network
There was a time when LSD and other vision-inducing psychedelic drugs were associated with the American counter-culture and for conservative observers with license and dissent …
Read Points History Article
A recent application from CB Therapeutics on biosynthetic psilocybin is emblematic of the IP concerns around novelty and obviousness the psychedelic field will face.
Read nxt psychedelics Article
Not everyone embraces the old psychedelic values of sharing and generosity. Today, as laws are changing, companies are filing a range of questionable patents that could let them control psychedelic molecules …
Read Psychedelic Times Article
The debate around psychedelic patents reflects a deeper question about how to create a business model that puts values before profits.
Read VICE Article
News that COMPASS Pathways is attempting to patent psychedelic therapy room specifications and therapist behaviors started an online firestorm about the company’s “monopolistic and shady behaviors,” …
Read Psymposia Article
Psychedelics now appear in patent applications for Philip Morris e-cigarettes, periodontal disease, hair loss, weight loss, and food allergies.
Read VICE Article